{"id":9485,"date":"2026-02-16T16:20:31","date_gmt":"2026-02-16T08:20:31","guid":{"rendered":"https:\/\/regask.com\/?p=9485"},"modified":"2026-02-16T16:20:31","modified_gmt":"2026-02-16T08:20:31","slug":"%e8%8b%b1%e5%9b%bd%e8%8d%af%e5%93%81%e5%92%8c%e4%bf%9d%e5%81%a5%e4%ba%a7%e5%93%81%e7%9b%91%e7%ae%a1%e7%bd%b2-mhra-%e5%8f%91%e5%b8%83%e4%ba%86%e5%85%b3%e4%ba%8e%e6%a0%b9%e6%8d%ae%e4%bf%ae%e8%ae%a2","status":"publish","type":"post","link":"https:\/\/regask.com\/zh\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/","title":{"rendered":"\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72\u53d1\u5e03\u836f\u7269\u8b66\u6212\u8981\u6c42\u6307\u5357\u2026\u2026"},"content":{"rendered":"<p>\u5728 <strong>2026\u5e742\u67089\u65e5,<\/strong> \u8fd9 <strong>\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u5c40\uff08MHRA\uff09<\/strong> \u82f1\u56fd\u836f\u54c1\u7ba1\u7406\u5c40\u53d1\u5e03\u4e86\u9488\u5bf9\u836f\u54c1\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u7684\u65b0\u6307\u5357\uff0c\u6982\u8ff0\u4e86\u5728\u4fee\u8ba2\u540e\u836f\u7269\u8b66\u6212\u8981\u6c42\u5c06\u5982\u4f55\u9002\u7528\u3002 <strong>\u59d4\u5458\u4f1a\u5b9e\u65bd\u6761\u4f8b\uff08CIR\uff09520\/2012\u3002.<\/strong> \u8be5\u6307\u5357\u53cd\u6620\u4e86\u6b27\u76df\u59d4\u5458\u4f1a\u7684\u91c7\u7eb3 <strong>\uff08\u6b27\u76df\uff092025\/1466 \u53f7\u6761\u4f8b,<\/strong> \u8be5\u4fee\u8ba2\u6848\u5bf9 CIR 520\/2012 \u8fdb\u884c\u4e86\u4fee\u6b63\uff0c\u5e76\u4e8e\u81ea[\u65e5\u671f]\u8d77\u751f\u6548\u3002 <strong>2026\u5e742\u670812\u65e5,<\/strong> \u90e8\u5206\u6761\u6b3e\u81ea[\u65e5\u671f]\u8d77\u751f\u6548 <strong>2025\u5e748\u670812\u65e5\u3002.<\/strong> \u6b64\u6b21\u66f4\u65b0\u5bf9\u6301\u6709\u80a1\u4efd\u7684\u7ec4\u7ec7\u5c24\u4e3a\u91cd\u8981\u3002 <strong>\u82f1\u56fd\u6388\u6743\u836f\u54c1<\/strong> \u5728\u4e0d\u540c\u7c7b\u522b\u4e0b <strong>\u6e29\u838e\u6846\u67b6\u3002. <\/strong><\/p>\n<div class=\"row\"  id=\"row-949789194\">\n\n\t<div id=\"col-1120799320\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n\t<div id=\"gap-1620003244\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1620003244 {\n  padding-top: 20px;\n}\n<\/style>\n\t<\/div>\n\t\n<h2>\u66f4\u65b0\u8be6\u60c5<\/h2>\n\t<div id=\"gap-233603545\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-233603545 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u8be5\u6307\u5357\u89e3\u91ca\u8bf4\uff1a <strong>CIR 520\/2012<\/strong> \u5df2\u7531\u2026\u2026\u6b63\u5f0f\u4fee\u8ba2 <strong>\uff08\u6b27\u76df\uff092025\/1466 \u53f7\u6761\u4f8b,<\/strong> \u5bf9\u836f\u7269\u8b66\u6212\u8981\u6c42\u8fdb\u884c\u4fee\u6539\u3002\u5b9e\u65bd\u4e4b\u540e<strong> \u6e29\u838e\u6846\u67b6,<\/strong> \u82f1\u56fd\u6388\u6743\u7684\u836f\u54c1\u73b0\u5728\u88ab\u5f52\u7c7b\u4e3a\uff1a <strong>\u7b2c\u4e00\u7c7b<\/strong> \u6216\u8005 <strong>\u7b2c\u4e8c\u7c7b,<\/strong> \u5b83\u51b3\u5b9a\u4e86\u9002\u7528\u7684\u6cd5\u5f8b\u6846\u67b6\u3002.<\/p>\n<p>\u4ece <strong>2026\u5e742\u670812\u65e5\uff0cHMR 2012\u9644\u886812A<\/strong> \u4ee5\u53ca\u4fee\u8ba2\u540e\u7684\u7248\u672c <strong>CIR 520\/2012<\/strong> \u5728\u836f\u7269\u8b66\u6212\u4e49\u52a1\u65b9\u9762\uff0c\u4e24\u8005\u7684\u6cd5\u5f8b\u89c4\u5b9a\u5c06\u4e0d\u518d\u4e00\u81f4\u3002\u8fd9\u79cd\u5dee\u5f02\u610f\u5473\u7740\uff0c\u6839\u636e\u4ea7\u54c1\u7c7b\u522b\u548c\u4ea7\u54c1\u7ec4\u5408\u7ed3\u6784\u7684\u4e0d\u540c\uff0c\u53ef\u80fd\u9002\u7528\u4e0d\u540c\u7684\u8981\u6c42\u3002.<\/p>\n<p>\u4e3a\u4e86\u51cf\u5c11\u4e0d\u5fc5\u8981\u7684\u76d1\u7ba1\u8d1f\u62c5\uff0cMHRA\u6982\u8ff0\u4e86 <strong>\u52a1\u5b9e\u7684\u5408\u89c4\u65b9\u6cd5<\/strong>. \u5e02\u573a\u6388\u6743\u6301\u6709\u4eba <strong>\u6df7\u5408\u6295\u8d44\u7ec4\u5408<\/strong> \u540c\u65f6\u5305\u542b\u7b2c\u4e00\u7c7b\u548c\u7b2c\u4e8c\u7c7b\u4ea7\u54c1\u7684\u4ed3\u5e93\uff0c\u5efa\u8bae\u91c7\u7528\u4fee\u8ba2\u540e\u7684\u89c4\u5b9a\u3002 <strong>CIR 520\/2012<\/strong> \u9002\u7528\u4e8e\u6240\u6709\u82f1\u56fd\u6388\u6743\u4ea7\u54c1\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u6301\u6709\u8005\u2026\u2026 <strong>\u7b2c\u4e00\u7c7b\u4ea7\u54c1<\/strong> <strong>\u4ec5\u6709\u7684<\/strong> \u53ef\u80fd\u7ee7\u7eed\u5173\u6ce8 <strong>HMR\u9644\u886812A\uff0c,<\/strong> \u9664\u975e\u4ed6\u4eec\u4e5f\u6301\u6709 <strong>\u6b27\u76df\u540c\u7b49\u6388\u6743<\/strong>, \u5728\u8fd9\u79cd\u60c5\u51b5\u4e0b\uff0c\u8fd8\u9700\u8003\u8651\u5176\u4ed6\u56e0\u7d20\u3002.<\/p>\n<p>MHRA\u8fd8\u6307\u51fa\uff0c\u672a\u6765\u7684\u66f4\u65b0\u5c06\u2026\u2026 <strong>HMR 2012 \u9644\u8868 12A<\/strong> \u53ef\u4ee5\u8003\u8651\u66f4\u597d\u5730\u53cd\u6620\u5bf9\u4ee5\u4e0b\u5185\u5bb9\u6240\u505a\u7684\u4fee\u6539\uff1a <strong>CIR 520\/2012\uff0c,<\/strong> \u5c3d\u7ba1\u76ee\u524d\u5c1a\u672a\u786e\u8ba4\u4efb\u4f55\u53d8\u66f4\u3002.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1120799320 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-822308848\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u751f\u6548\u65e5\u671f<\/h2>\n\t<div id=\"gap-254014427\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-254014427 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u4fee\u8ba2\u540e\u7684 <strong>\u59d4\u5458\u4f1a\u5b9e\u65bd\u6761\u4f8b\uff08CIR\uff09520\/2012\uff0c,<\/strong> \u7ecf\u4fee\u8ba2 <strong>\uff08\u6b27\u76df\uff092025\/1466 \u53f7\u6761\u4f8b\u81ea 2026 \u5e74 2 \u6708 12 \u65e5\u8d77\u751f\u6548\u3002.<\/strong> \u7136\u800c\uff0c, <strong>\u7b2c 1(7) \u6761\u548c\u7b2c 1(9) \u6761<\/strong> \u4fee\u8ba2\u6761\u4f8b <strong>\u751f\u6548\u65e5\u671f\u8f83\u65e9\uff0c\u4e3a 2025 \u5e74 8 \u6708 12 \u65e5\u3002. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-822308848 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1219978747\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u4e3a\u4ec0\u4e48\u91cd\u8981<\/h2>\n\t<div id=\"gap-308603763\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-308603763 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u672c\u6b21\u66f4\u65b0\u5f15\u5165\u4e86 <strong>\u82f1\u56fd\u548c\u6b27\u76df\u836f\u7269\u8b66\u6212\u6cd5\u5f8b\u6846\u67b6\u4e0d\u4e00\u81f4\uff0c,<\/strong> \u4e3a\u5408\u89c4\u89c4\u5212\u521b\u9020\u5b9e\u9645\u610f\u4e49\u3002MHRA \u7684\u52a1\u5b9e\u65b9\u6cd5\u65e8\u5728\u63d0\u4f9b\u652f\u6301 <strong>\u76d1\u7ba1\u6e05\u6670\u5ea6\u3001\u8fd0\u8425\u6548\u7387,<\/strong> \u548c <strong>\u6570\u5b57\u5bf9\u51c6,<\/strong> \u8fd9\u8fd8\u8981\u6c42\u5404\u7ec4\u7ec7\u8c28\u614e\u7ba1\u7406\u6d41\u7a0b\uff0c\u4ee5\u907f\u514d\u8bef\u7528\u76f8\u5173\u8981\u6c42\u3002\u8fd9\u4e9b\u53d8\u5316\u53ef\u80fd\u9700\u8981\u5bf9\u836f\u7269\u8b66\u6212\u7cfb\u7edf\u3001\u6cbb\u7406\u7ed3\u6784\u548c\u5185\u90e8\u7a0b\u5e8f\u8fdb\u884c\u6709\u9488\u5bf9\u6027\u7684\u66f4\u65b0\uff0c\u5c24\u5176\u5bf9\u4e8e\u4ea7\u54c1\u7ec4\u5408\u590d\u6742\u6216\u6df7\u5408\u7684\u7ec4\u7ec7\u800c\u8a00\u66f4\u662f\u5982\u6b64\u3002.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1219978747 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1775446971\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u8fd9\u9002\u7528\u4e8e\u54ea\u4e9b\u4eba\u7fa4<\/h2>\n\t<div id=\"gap-2096637134\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-2096637134 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u8be5\u6307\u5357\u9002\u7528\u4e8e <strong>\u836f\u7269\u8b66\u6212\u3001\u6cd5\u89c4\u4e8b\u52a1\u3001\u8d28\u91cf\u4fdd\u8bc1\u3001\u5408\u89c4\u6027,<\/strong> \u6211<strong>\u6570\u5b57\u6cbb\u7406\u56e2\u961f<\/strong> \u8d1f\u8d23\u7ba1\u7406\u82f1\u56fd\u6388\u6743\u7684\u836f\u54c1\u548c\u8de8\u53f8\u6cd5\u7ba1\u8f96\u533a\u7684\u76d1\u7ba1\u4e49\u52a1\u3002.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1775446971 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-229194553\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h2>\u4e0b\u4e00\u6b65<\/h2>\n\t<div id=\"gap-1331807736\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1331807736 {\n  padding-top: 15px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u5404\u7ec4\u7ec7\u5e94\u5ba1\u67e5\u5176 <strong>\u82f1\u56fd\u4ea7\u54c1\u7ec4\u5408<\/strong> \u786e\u8ba4\u4ea7\u54c1\u662f\u5426\u5c5e\u4e8e <strong>\u7b2c\u4e00\u7c7b\u6216\u7b2c\u4e8c\u7c7b<\/strong> \u5e76\u8bc4\u4f30\u662f\u5426\u5b58\u5728\u4efb\u4f55 <strong>\u6b27\u76df\u540c\u7b49\u8bb8\u53ef\u8bc1<\/strong>. \u5185\u90e8\u836f\u7269\u8b66\u6212\u7a0b\u5e8f\u3001\u51b3\u7b56\u6846\u67b6\u548c\u6cbb\u7406\u6a21\u5f0f\u5e94\u5bf9\u7167\u5df2\u660e\u786e\u9884\u671f\u8fdb\u884c\u68c0\u67e5\uff0c\u5e76\u4e8b\u5148\u8fdb\u884c\u8de8\u90e8\u95e8\u534f\u8c03\u3002 <strong>2026\u5e742\u670812\u65e5<\/strong> \u751f\u6548\u65e5\u671f\u65e8\u5728\u6700\u5927\u7a0b\u5ea6\u5730\u964d\u4f4e\u5408\u89c4\u98ce\u9669\u3002.<\/p>\n<p>\u968f\u7740\u76d1\u7ba1\u5dee\u5f02\u589e\u52a0\u8fd0\u8425\u590d\u6742\u6027\uff0c\u5efa\u7acb\u7ed3\u6784\u5316\u7684\u65b9\u6cd5\u6765\u76d1\u63a7\u53d8\u5316\u5e76\u8bc4\u4f30\u5176\u5f71\u54cd\u53d8\u5f97\u8d8a\u6765\u8d8a\u91cd\u8981\u3002. <strong><a href=\"http:\/\/regask.com\/zh\/\">RegASK<\/a> \u662f\u4e00\u4e2a\u9886\u5148\u7684\u667a\u80fd\u4f53\u4eba\u5de5\u667a\u80fd\u76d1\u7ba1\u60c5\u62a5\u548c\u5de5\u4f5c\u6d41\u7f16\u6392\u5e73\u53f0<\/strong> \u5b83\u8d4b\u80fd\u5168\u7403\u7ec4\u7ec7\uff0c\u4f7f\u5176\u80fd\u591f\u79ef\u6781\u5e94\u5bf9\u5305\u62ec\u751f\u547d\u79d1\u5b66\u5728\u5185\u7684\u9ad8\u5ea6\u76d1\u7ba1\u884c\u4e1a\u7684\u4e0d\u65ad\u53d8\u5316\u7684\u76d1\u7ba1\u73af\u5883\u3002\u901a\u8fc7\u7ed3\u5408\u5148\u8fdb\u7684\u6280\u672f\uff0c <strong>\u4e13\u5bb6\u53c2\u4e0e\u7684\u667a\u80fd\u4f53\u4eba\u5de5\u667a\u80fd, <a href=\"http:\/\/regask.com\/zh\/\">RegASK<\/a><\/strong> \u63d0\u4f9b\u53ca\u65f6\u3001\u9884\u6d4b\u6027\u548c\u53ef\u64cd\u4f5c\u7684\u89c1\u89e3\uff0c\u5e2e\u52a9\u56e2\u961f\u7b80\u5316\u5408\u89c4\u6d41\u7a0b\uff0c\u5e76\u5728 160 \u591a\u4e2a\u56fd\u5bb6\/\u5730\u533a\u4fdd\u6301\u76d1\u7ba1\u3002.<strong> <a href=\"http:\/\/regask.com\/zh\/\">\u4e86\u89e3\u66f4\u591a<\/a><\/strong> \u6216\u8005 <strong><a href=\"https:\/\/regask.com\/zh\/%e9%a2%84%e8%ae%a2%e6%bc%94%e7%a4%ba\/\">\u7acb\u5373\u9884\u8ba2\u6f14\u793a\u3002\u00a0<\/a><\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-229194553 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>\n<div class=\"row\"  id=\"row-1658587117\">\n\n\t<div id=\"col-796439163\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<div class=\"is-divider divider clearfix\" style=\"margin-top:2em;margin-bottom:2em;max-width:20%;height:1px;background-color:#a5acd9;\"><\/div>\n<h3>\u5e38\u89c1\u95ee\u9898\u89e3\u7b54<\/h3>\n\t<div id=\"gap-1717814215\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1717814215 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<h4><span class=\"TextRun MacChromeBold SCXW240545805 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW240545805 BCX0\">\u4ec0\u4e48\u662f\u59d4\u5458\u4f1a\u5b9e\u65bd\u6761\u4f8b 520\/2012\uff1f<\/span><\/span><span class=\"EOP SCXW240545805 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/h4>\n\t<div id=\"gap-760821321\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-760821321 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><span class=\"TextRun SCXW37803039 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW37803039 BCX0\">\u8fd9\u662f\u4e00\u9879\u6b27\u76df\u6cd5\u89c4\uff0c\u5176\u4e2d\u8be6\u7ec6\u89c4\u5b9a\u4e86\u2026\u2026<strong>\u00a0<\/strong><\/span><\/span><strong><span class=\"TextRun MacChromeBold SCXW37803039 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW37803039 BCX0\">\u836f\u7269\u8b66\u6212\u8981\u6c42<\/span><\/span><\/strong><span class=\"TextRun SCXW37803039 BCX0\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW37803039 BCX0\">\u00a0\u836f\u54c1\u8425\u9500\u4e49\u52a1\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW37803039 BCX0\">\u6388\u6743<\/span><span class=\"NormalTextRun SCXW37803039 BCX0\">\u00a0\u6301\u6709\u8005\u3002.<\/span><\/span><span class=\"EOP SCXW37803039 BCX0\" data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;335559738&quot;:240,&quot;335559739&quot;:240}\">\u00a0<\/span><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-796439163 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-904178844\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u6b27\u76df\u7b2c 2025\/1466 \u53f7\u6761\u4f8b\u6539\u53d8\u4e86\u4ec0\u4e48\uff1f<\/h4>\n\t<div id=\"gap-1159548201\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-1159548201 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\uff08\u6b27\u76df\uff092025\/1466\u53f7\u6761\u4f8b<strong> \u4fee\u8ba2 CIR 520\/2012\uff0c,<\/strong> \u4fee\u8ba2\u836f\u7269\u8b66\u6212\u8981\u6c42\u5e76\u5e94\u7528 <strong>2026\u5e742\u670812\u65e5,<\/strong> \u90e8\u5206\u6761\u6b3e\u81ea[\u65e5\u671f]\u8d77\u751f\u6548<strong> 2025\u5e748\u670812\u65e5\u3002. <\/strong><\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-904178844 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1234976449\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>\u300a\u6e29\u838e\u6846\u67b6\u300b\u5982\u4f55\u5f71\u54cd\u82f1\u56fd\u7684\u836f\u7269\u8b66\u6212\u4e49\u52a1\uff1f<\/h4>\n\t<div id=\"gap-37590706\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-37590706 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p>\u6e29\u838e\u6846\u67b6\u5f15\u5165\u4e86 <strong>\u7b2c\u4e00\u7c7b\u548c\u7b2c\u4e8c\u7c7b\u5206\u7c7b<\/strong> \u5bf9\u4e8e\u82f1\u56fd\u6388\u6743\u7684\u836f\u54c1\uff0c\u7ed3\u679c\u662f<strong> \u4e0d\u540c\u7684\u9002\u7528\u6cd5\u5f8b\u6846\u67b6 <\/strong>\u7528\u4e8e\u836f\u7269\u8b66\u6212\u3002.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1234976449 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n\n\t<div id=\"col-1431909617\" class=\"col small-12 large-12\"  >\n\t\t\t\t<div class=\"col-inner\"  >\n\t\t\t\n\t\t\t\n<h4>H<span class=\"NormalTextRun SCXW207083187 BCX0\">\u73b0\u5728\u53ef\u4ee5\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW207083187 BCX0\">RegASK<\/span><span class=\"NormalTextRun SCXW207083187 BCX0\">\u00a0\u5e2e\u52a9\u00a0<\/span><span class=\"NormalTextRun SpellingErrorV2Themed SCXW207083187 BCX0\">\u7ec4\u7ec7<\/span><span class=\"NormalTextRun SCXW207083187 BCX0\">\u00a0\u5982\u4f55\u5e94\u5bf9\u8fd9\u4e9b\u53d8\u5316\uff1f<\/span><\/h4>\n\t<div id=\"gap-29014367\" class=\"gap-element clearfix\" style=\"display:block; height:auto;\">\n\t\t\n<style>\n#gap-29014367 {\n  padding-top: 10px;\n}\n<\/style>\n\t<\/div>\n\t\n<p><a href=\"http:\/\/regask.com\/zh\/\"><strong>RegASK<\/strong><\/a> \u5e2e\u52a9\u56e2\u961f\u8ddf\u8e2a <strong>\u76d1\u7ba1\u52a8\u6001\u66f4\u65b0,<\/strong> \u8bc4\u4f30 <strong>\u6295\u8d44\u7ec4\u5408\u7279\u5b9a\u5f71\u54cd\uff0c,<\/strong> \u5e76\u534f\u8c03 <strong>\u5408\u89c4\u5de5\u4f5c\u6d41\u7a0b,<\/strong> \u4ece\u800c\u80fd\u591f\u66f4\u6709\u6548\u5730\u7ba1\u7406\u82f1\u56fd\u548c\u6b27\u76df\u4e4b\u95f4\u4e0d\u540c\u7684\u836f\u7269\u8b66\u6212\u8981\u6c42\u3002.<\/p>\n\t\t<\/div>\n\t\t\t\t\n<style>\n#col-1431909617 > .col-inner {\n  margin: 0px 0px -20px 0px;\n}\n<\/style>\n\t<\/div>\n\n\t\n<\/div>","protected":false},"excerpt":{"rendered":"<p>On 9 February 2026, the UK Medicines and Healthcare products Regulatory Agency (MHRA) published new guidance for UK Marketing Authorisation Holders outlining how pharmacovigilance requirements will apply following amendments to Commission Implementing Regulation (CIR) 520\/2012. The guidance reflects the European Commission\u2019s adoption of Regulation (EU) 2025\/1466, which revises CIR 520\/2012 and becomes applicable from 12&#8230;<\/p>","protected":false},"author":41,"featured_media":9486,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[33,526,35],"tags":[],"class_list":["post-9485","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-united-kingdom-regulations","category-pharma-biotech-latest-insights"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UK MHRA Issues Guidance on Pharmacovigilance Overview<\/title>\n<meta name=\"description\" content=\"Explore the UK MHRA&#039;s new guidance on pharmacovigilance requirements under amended CIR 520\/2012 for UK Marketing Authorisation Holders.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/zh\/\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72-mhra-\u53d1\u5e03\u4e86\u5173\u4e8e\u6839\u636e\u4fee\u8ba2\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UK MHRA Issues Guidance on Pharmacovigilance Requirements Under Amended CIR 520\/2012\" \/>\n<meta property=\"og:description\" content=\"Explore the UK MHRA&#039;s new guidance on pharmacovigilance requirements under amended CIR 520\/2012 for UK Marketing Authorisation Holders.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/zh\/\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72-mhra-\u53d1\u5e03\u4e86\u5173\u4e8e\u6839\u636e\u4fee\u8ba2\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-16T08:20:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png\" \/>\n\t<meta property=\"og:image:width\" content=\"904\" \/>\n\t<meta property=\"og:image:height\" content=\"622\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Shaffa Renaningtyas\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Shaffa Renaningtyas\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/\"},\"author\":{\"name\":\"Shaffa Renaningtyas\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\"},\"headline\":\"UK MHRA Issues Guidance on Pharmacovigilance Requiremen&hellip;\",\"datePublished\":\"2026-02-16T08:20:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/\"},\"wordCount\":798,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png\",\"articleSection\":[\"Regulatory News\",\"United Kingdom\",\"Pharma and Biotech\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/\",\"name\":\"UK MHRA Issues Guidance on Pharmacovigilance Overview\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png\",\"datePublished\":\"2026-02-16T08:20:31+00:00\",\"description\":\"Explore the UK MHRA's new guidance on pharmacovigilance requirements under amended CIR 520\\\/2012 for UK Marketing Authorisation Holders.\",\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2026\\\/02\\\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png\",\"width\":904,\"height\":622,\"caption\":\"Uk Mhra Issues Guidance Pharmacovigilance Requirements Amended Cir 520 2012\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"Empowering Smarter Regulatory Decisions\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-Hans\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/b0e1938ef6f244f9f052a21f21cba1b6\",\"name\":\"Shaffa Renaningtyas\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72\u53d1\u5e03\u836f\u7269\u8b66\u6212\u6982\u8ff0\u6307\u5357","description":"\u4e86\u89e3\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72 (MHRA) \u6839\u636e\u4fee\u8ba2\u540e\u7684 CIR 520\/2012 \u9488\u5bf9\u82f1\u56fd\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u5236\u5b9a\u7684\u836f\u7269\u8b66\u6212\u8981\u6c42\u7684\u65b0\u6307\u5357\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/zh\/\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72-mhra-\u53d1\u5e03\u4e86\u5173\u4e8e\u6839\u636e\u4fee\u8ba2\/","og_locale":"zh_CN","og_type":"article","og_title":"UK MHRA Issues Guidance on Pharmacovigilance Requirements Under Amended CIR 520\/2012","og_description":"Explore the UK MHRA's new guidance on pharmacovigilance requirements under amended CIR 520\/2012 for UK Marketing Authorisation Holders.","og_url":"https:\/\/regask.com\/zh\/\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72-mhra-\u53d1\u5e03\u4e86\u5173\u4e8e\u6839\u636e\u4fee\u8ba2\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2026-02-16T08:20:31+00:00","og_image":[{"width":904,"height":622,"url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png","type":"image\/png"}],"author":"Shaffa Renaningtyas","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"\u4f5c\u8005":"Shaffa Renaningtyas","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"4 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/#article","isPartOf":{"@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/"},"author":{"name":"Shaffa Renaningtyas","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6"},"headline":"UK MHRA Issues Guidance on Pharmacovigilance Requiremen&hellip;","datePublished":"2026-02-16T08:20:31+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/"},"wordCount":798,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png","articleSection":["Regulatory News","United Kingdom","Pharma and Biotech"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/","url":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/","name":"\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72\u53d1\u5e03\u836f\u7269\u8b66\u6212\u6982\u8ff0\u6307\u5357","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png","datePublished":"2026-02-16T08:20:31+00:00","description":"\u4e86\u89e3\u82f1\u56fd\u836f\u54c1\u548c\u4fdd\u5065\u4ea7\u54c1\u76d1\u7ba1\u7f72 (MHRA) \u6839\u636e\u4fee\u8ba2\u540e\u7684 CIR 520\/2012 \u9488\u5bf9\u82f1\u56fd\u4e0a\u5e02\u8bb8\u53ef\u6301\u6709\u4eba\u5236\u5b9a\u7684\u836f\u7269\u8b66\u6212\u8981\u6c42\u7684\u65b0\u6307\u5357\u3002.","inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/"]}]},{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/uk-mhra-issues-guidance-on-pharmacovigilance-requirements-under-amended-cir-520-2012\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2026\/02\/uk-mhra-issues-guidance-pharmacovigilance-requirements-amended-cir-520-2012.png","width":904,"height":622,"caption":"Uk Mhra Issues Guidance Pharmacovigilance Requirements Amended Cir 520 2012"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"\u52a9\u529b\u66f4\u660e\u667a\u7684\u76d1\u7ba1\u51b3\u7b56","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-Hans","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/playlist?list=PL6yPC6gFqelkHbOeyUVKjtHOZXZ2LQbJd"]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/b0e1938ef6f244f9f052a21f21cba1b6","name":"\u6c99\u6cd5\u00b7\u96f7\u7eb3\u5b81\u8482\u4e9a\u65af"}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/9485","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/users\/41"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/comments?post=9485"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/posts\/9485\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media\/9486"}],"wp:attachment":[{"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/media?parent=9485"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/categories?post=9485"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/zh\/wp-json\/wp\/v2\/tags?post=9485"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}